Your browser doesn't support javascript.
loading
Thrombus Migration and Fragmentation After Intravenous Alteplase Treatment: The INTERRSeCT Study.
Ohara, Tomoyuki; Menon, Bijoy K; Al-Ajlan, Fahad S; Horn, MacKenzie; Najm, Mohamed; Al-Sultan, Abdulaziz; Puig, Josep; Dowlatshahi, Dar; Calleja Sanz, Ana I; Sohn, Sung-Il; Ahn, Seong H; Poppe, Alexandre Y; Mikulik, Robert; Asdaghi, Negar; Field, Thalia S; Jin, Albert; Asil, Talip; Boulanger, Jean-Martin; Letteri, Federica; Dey, Sadanand; Evans, James W; Goyal, Mayank; Hill, Michael D; Almekhlafi, Mohammed; Demchuk, Andrew M.
Afiliação
  • Ohara T; Calgary Stroke Program, Hotchkiss Brain Institute, Departments of Clinical Neurosciences and Radiology, Cumming School of Medicine, University of Calgary, Canada (T.O., B.K.M., M.H., M.N., A.A.-S., M.G., M.D.H., M.A., A.M.D.).
  • Menon BK; Department of Neurology, Kyoto Prefectural University of Medicine, Kyoto, Japan (T.O.).
  • Al-Ajlan FS; Calgary Stroke Program, Hotchkiss Brain Institute, Departments of Clinical Neurosciences and Radiology, Cumming School of Medicine, University of Calgary, Canada (T.O., B.K.M., M.H., M.N., A.A.-S., M.G., M.D.H., M.A., A.M.D.).
  • Horn M; King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia (F.S.A.-A.).
  • Najm M; Calgary Stroke Program, Hotchkiss Brain Institute, Departments of Clinical Neurosciences and Radiology, Cumming School of Medicine, University of Calgary, Canada (T.O., B.K.M., M.H., M.N., A.A.-S., M.G., M.D.H., M.A., A.M.D.).
  • Al-Sultan A; Calgary Stroke Program, Hotchkiss Brain Institute, Departments of Clinical Neurosciences and Radiology, Cumming School of Medicine, University of Calgary, Canada (T.O., B.K.M., M.H., M.N., A.A.-S., M.G., M.D.H., M.A., A.M.D.).
  • Puig J; Calgary Stroke Program, Hotchkiss Brain Institute, Departments of Clinical Neurosciences and Radiology, Cumming School of Medicine, University of Calgary, Canada (T.O., B.K.M., M.H., M.N., A.A.-S., M.G., M.D.H., M.A., A.M.D.).
  • Dowlatshahi D; IDI-IDIBGI, Dr Josep Trueta University Hospital, Girona, Spain (J.P.).
  • Calleja Sanz AI; Department of Medicine, University of Ottawa and Ottawa Hospital Research Institute, Canada (D.D.).
  • Sohn SI; Department of Neurology, Universitary Clinical Hospital of Valladolid, Spain (A.I.C.-S.).
  • Ahn SH; Department of Neurology, Keimyung University, Daegu, Republic of Korea (S.-I.S.).
  • Poppe AY; Gwangju Institute of Science and Technology, Republic of Korea (S.H.A.).
  • Mikulik R; Department of Neurosciences, University of Montreal, Canada (A.Y.P.).
  • Asdaghi N; International Clinical Research Center, Department of Neurology, St Anne's University Hospital, Masaryk University, Brno, Czech Republic (R.M.).
  • Field TS; University of Miami, FL (N.A.).
  • Jin A; Division of Neurology, University of British Columbia, Vancouver, British Columbia, Canada (T.S.F.).
  • Asil T; Department of Medicine (Neurology), Queen's University, Kingston, Ontario, Canada (A.J.).
  • Boulanger JM; Bezmialem Vakif Univesitesi Noroloji, Istanbul, Turkey (T.A.).
  • Letteri F; Charles LeMoyne Hospital, Greenfield Park, QC, Canada (J.-M.B.).
  • Dey S; Istituto Don Calabria, IRCCS Sacro Cuore Hospital, Negrar, Italy (F.L.).
  • Evans JW; AMRI, Mukundapur, Kolkata, India (S.D.).
  • Goyal M; Gosford Hospital, Gosford, NSW, Australia (J.W.E.).
  • Hill MD; Calgary Stroke Program, Hotchkiss Brain Institute, Departments of Clinical Neurosciences and Radiology, Cumming School of Medicine, University of Calgary, Canada (T.O., B.K.M., M.H., M.N., A.A.-S., M.G., M.D.H., M.A., A.M.D.).
  • Almekhlafi M; Calgary Stroke Program, Hotchkiss Brain Institute, Departments of Clinical Neurosciences and Radiology, Cumming School of Medicine, University of Calgary, Canada (T.O., B.K.M., M.H., M.N., A.A.-S., M.G., M.D.H., M.A., A.M.D.).
  • Demchuk AM; Calgary Stroke Program, Hotchkiss Brain Institute, Departments of Clinical Neurosciences and Radiology, Cumming School of Medicine, University of Calgary, Canada (T.O., B.K.M., M.H., M.N., A.A.-S., M.G., M.D.H., M.A., A.M.D.).
Stroke ; 52(1): 203-212, 2021 01.
Article em En | MEDLINE | ID: mdl-33317416
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ativador de Plasminogênio Tecidual / Acidente Vascular Cerebral / Trombose Intracraniana / Fibrinolíticos Tipo de estudo: Prognostic_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Stroke Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ativador de Plasminogênio Tecidual / Acidente Vascular Cerebral / Trombose Intracraniana / Fibrinolíticos Tipo de estudo: Prognostic_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Stroke Ano de publicação: 2021 Tipo de documento: Article